Related Experiment Video
Updated: Jul 7, 2026
A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
Published on: September 21, 2021
Pediatric Cardiac Xenotransplantation: Recommendations for the Ethical Design of Clinical Trials
Daniel J Hurst1, Luz Padilla2, Anthony Merlocco3
1Department of Family Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ.
Insights
Cardiac xenotransplantation offers a potential solution for children with complex heart conditions facing long waitlists. This review examines the ethical considerations for pediatric heart xenotransplantation trials.
Area of Science:
- Biomedical Ethics
- Pediatric Cardiology
- Xenotransplantation Research
Background:
- Pediatric cardiac allotransplantation is limited by donor heart availability, leading to high mortality rates.
- Cardiac xenotransplantation is a proposed alternative for infants and neonates, potentially serving as a bridge or replacement for allografts.
- While adult xenotransplantation ethics are emerging, pediatric-specific ethical issues remain underexplored.
Purpose of the Study:
- To summarize and analyze the unique ethical issues surrounding pediatric cardiac xenotransplantation.
- To inform the ethical design of future pediatric heart xenotransplantation clinical trials.
Main Methods:
- Literature review and ethical analysis of key issues in pediatric cardiac xenotransplantation.
- Focus on recipient selection, informed consent, and psychosocial aspects.
Main Results:
- Identified key ethical considerations including the priority of adult vs. pediatric trials, criteria for pediatric recipient selection, challenges in obtaining informed consent from minors, and public perception.
- Highlighted the need for specific ethical frameworks for pediatric xenotransplantation.
Conclusions:
- Pediatric cardiac xenotransplantation presents distinct ethical challenges requiring careful consideration.
- Recommendations are provided for ethically sound design and implementation of pediatric heart xenotransplantation trials.
Abstract:
For children with complex congenital heart problems, cardiac allotransplantation is sometimes the best therapeutic option. However, availability of hearts for pediatric patients is limited, resulting in a long and growing waitlist, and a high mortality rate while waiting. Cardiac xenotransplantation has been proposed as one therapeutic alternative for neonates and infants, either in lieu of allotransplantation or as a bridge until an allograft becomes available. Scientific and clinical developments in xenotransplantation appear likely to permit cardiac xenotransplantation clinical trials in adults in the coming years. The ethical issues around xenotransplantation of the heart and other organs and tissues have recently been examined, but to date, only limited literature is available on the ethical issues that are attendant with pediatric heart xenotransplantation. Here, we summarize the ethical issues, focusing on (1) whether cardiac xenotransplantation should proceed in adults or children first, (2) pediatric recipient selection for initial xenotransplantation trials, (3) special problems regarding informed consent in this context, and (4) related psychosocial and public perception considerations. We conclude with specific recommendations regarding ethically informed design of pediatric heart xenotransplantation trials.
More Related Videos
08:30A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
12:40A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
